Carlsson, S.

screening cancer prostate study prostate cancer mortality biopsy follow-up control arm effect erspc death disease pc-speci fic mortality control trial reduction number diagnosis treatment european randomized study result rotterdam group incidence gothenburg european randomized table prostate biopsy center screening arm population health university model prostate-cancer intervention arm interval screening-positive roobol insulator urology life-year utility chromatin pc incidence intervention randomization utility estimates interaction screening-positive men roobol mj metastatic disease sweden estimate pc-speci period centre erasmus university biopsied metastatic schroder figure overdiagnosi base model complication biopsy indication england journal nejm.org netherland quality domain therapy stage analysis transrectal medicine downloaded npc domains prostate-cancer mortality